ABUS is Arbutus Biopharma Corporation (Healthcare) — a non-dividend-paying stock. Trading at $5.10. Market cap: $1.01B. Capital Quality Rank: 87/100 — Elite compounder.
Stock snapshot
| Price | $5.10 |
| Market cap | $1.01B |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 87 / 100 · Elite compounder |
| ROIC (TTM) | -48.6% |
| Revenue CAGR (3y) | -28.8% |
| Shareholder buyback yield | -3.13% |
| Altman Z-score zone | Safe |
About ABUS
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
Related non-dividend companies
Other non-dividend stocks investors research alongside ABUS. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is ABUS's current stock price?
ABUS (Arbutus Biopharma Corporation) is currently trading at $5.10.
Does ABUS pay a dividend?
ABUS (Arbutus Biopharma Corporation) does not currently pay a regular dividend.
What is ABUS's Capital Quality Rank?
ABUS has a Capital Quality Rank of 87/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track ABUS in DiviDrip
Add ABUS to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search ABUS and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.